Your browser doesn't support javascript.
loading
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Chhabra, Saurabh; Liu, Ying; Hemmer, Michael T; Costa, Luciano; Pidala, Joseph A; Couriel, Daniel R; Alousi, Amin M; Majhail, Navneet S; Stuart, Robert K; Kim, Dennis; Ringden, Olle; Urbano-Ispizua, Alvaro; Saad, Ayman; Savani, Bipin N; Cooper, Brenda; Marks, David I; Socie, Gerard; Schouten, Harry C; Schoemans, Helene; Abdel-Azim, Hisham; Yared, Jean; Cahn, Jean-Yves; Wagner, John; Antin, Joseph H; Verdonck, Leo F; Lehmann, Leslie; Aljurf, Mahmoud D; MacMillan, Margaret L; Litzow, Mark R; Solh, Melhem M; Qayed, Muna; Hematti, Peiman; Kamble, Rammurti T; Vij, Ravi; Hayashi, Robert J; Gale, Robert P; Martino, Rodrigo; Seo, Sachiko; Hashmi, Shahrukh K; Nishihori, Taiga; Teshima, Takanori; Gergis, Usama; Inamoto, Yoshihiro; Spellman, Stephen R; Arora, Mukta; Hamilton, Betty K.
Afiliação
  • Chhabra S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: schhabra@mcw.edu.
  • Liu Y; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Institute for Health and Society, Department of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hemmer MT; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Costa L; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Pidala JA; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Couriel DR; Division of Hematology and Hematologic Malignancies, Utah Blood and Marrow Transplant Program, Salt Lake City, Utah.
  • Alousi AM; Department of Stem Cell Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Stuart RK; Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Kim D; Department of Medical Oncology & Hematology, Princess Margaret Cancer Center, Toronto, Canada.
  • Ringden O; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Urbano-Ispizua A; Department of Hematology, IDIBAPS, Institute of Research Josep Carreras, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Saad A; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Cooper B; Department of Medicine-Hematology and Oncology, University Hospitals Case Medical Center, Cleveland, Ohio.
  • Marks DI; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Socie G; Department of Hematology, Hôpital Saint Louis, Paris, France.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, the Netherlands.
  • Schoemans H; Department of Hematology, 26-Department of Pediatrics, University Hospital of Leuven, Leuven, Belgium.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Yared J; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Wagner J; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Antin JH; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Verdonck LF; Departmentt of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands.
  • Lehmann L; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Aljurf MD; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • MacMillan ML; University of Minnesota Blood and Marrow Transplant Program, Minneapolis, Minnesota.
  • Litzow MR; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Solh MM; Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Qayed M; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
  • Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Vij R; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Hayashi RJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Martino R; Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Seo S; Department of Hematology & Oncology, National Cancer Research Center East, Chiba, Japan.
  • Hashmi SK; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Teshima T; Department of Hematology Kyushu University Hospital, Sapporo, Japan.
  • Gergis U; Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.
  • Inamoto Y; Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Spellman SR; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.
  • Arora M; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota. Electronic address: arora005@umn.edu.
  • Hamilton BK; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
Biol Blood Marrow Transplant ; 25(1): 73-85, 2019 01.
Article em En | MEDLINE | ID: mdl-30153491
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article